MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume 47, Issue 1, Pages 2800-2809
Publisher
Informa UK Limited
Online
2019-07-09
DOI
10.1080/21691401.2019.1638791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3
- (2018) Xiangdong Bai et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
- (2018) Zhi-Xue Yang et al. Cancer Cell International
- Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway
- (2018) Yajuan Xiao et al. CANCER LETTERS
- Triple negative breast cancer in Asia: An insider’s view
- (2018) Chao Wang et al. CANCER TREATMENT REVIEWS
- Layer-by-Layer Assembled Gold Nanoshells for the Intracellular Delivery of miR-34a
- (2018) Ritu Goyal et al. Cellular and Molecular Bioengineering
- miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer
- (2018) Huaping Xiong et al. CELLULAR SIGNALLING
- MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
- (2018) Hua Chen et al. Molecular Cancer
- Design, development and evaluation of microRNA-199a-5p detecting electrochemical nanobiosensor with diagnostic application in Triple Negative Breast Cancer
- (2018) Ammar Ebrahimi et al. TALANTA
- Reversal of Triple-negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immune-Suppression
- (2018) Thomas J. Rogers et al. MOLECULAR CANCER RESEARCH
- MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells
- (2018) Sofia Aakko et al. Translational Oncology
- Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer
- (2017) Min Hye Jang et al. HUMAN PATHOLOGY
- Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors
- (2017) Zilan Zhou et al. Nanomedicine-Nanotechnology Biology and Medicine
- miR-520h is crucial for DAPK2 regulation and breast cancer progression
- (2017) C-M Su et al. ONCOGENE
- miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers
- (2017) Insaf Fkih M’hamed et al. PATHOLOGY & ONCOLOGY RESEARCH
- Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
- (2017) Zhihao Zeng et al. YONSEI MEDICAL JOURNAL
- Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
- (2017) Ling Deng et al. Oncotarget
- MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
- (2017) Zhendong Shi et al. Journal of Cancer
- miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5
- (2017) Wenhui Zhou et al. PLoS One
- Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer
- (2016) Zhongxing Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’
- (2016) Vivian Y Shin et al. BRITISH JOURNAL OF CANCER
- MiR-34a modulates ErbB2 in breast cancer
- (2016) Yilin Wang et al. CELL BIOLOGY INTERNATIONAL
- miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2
- (2016) Zhongming Jia et al. GENE
- MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer
- (2016) Long-ji Luo et al. GENE
- miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1
- (2016) Sukanya Shyamasundar et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
- (2016) Shengpeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer
- (2016) MEISI YAN et al. ONCOLOGY REPORTS
- A current perspective on stereotactic body radiation therapy for pancreatic cancer
- (2016) Julian Hong et al. OncoTargets and Therapy
- MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer
- (2016) Xin Xu et al. Oncotarget
- MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
- (2016) Lingmi Hou et al. MEDICAL SCIENCE MONITOR
- Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
- (2015) Dan Shu et al. ACS Nano
- Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
- (2015) Rammohan Devulapally et al. ACS Nano
- Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
- (2015) Yan Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer
- (2015) Peng Liu et al. CANCER LETTERS
- miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
- (2015) B. D. Adams et al. CANCER RESEARCH
- miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of theEPHA2oncogene
- (2015) Efrosini Tsouko et al. CARCINOGENESIS
- Small molecules targeting microRNA for cancer therapy: Promises and obstacles
- (2015) Di Wen et al. JOURNAL OF CONTROLLED RELEASE
- Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients
- (2015) Eman A. Toraih et al. Molecular Diagnosis & Therapy
- Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
- (2015) J Niu et al. ONCOGENE
- Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer
- (2015) Qingying Wang et al. TUMOR BIOLOGY
- Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development
- (2015) Chuan Jin et al. TUMOR BIOLOGY
- Triple-negative breast cancer: new perspectives for targeted therapies
- (2015) Silverio Tomao et al. OncoTargets and Therapy
- Identification of novel long non-coding RNAs in triple-negative breast cancer
- (2015) Xiaokun Shen et al. Oncotarget
- miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
- (2015) Keith O’Brien et al. Oncotarget
- Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer
- (2015) Lyndsay V. Rhodes et al. Oncotarget
- MiR-27a Modulates Radiosensitivity of Triple-Negative Breast Cancer (TNBC) Cells by Targeting CDC27
- (2015) Jianjun Han MEDICAL SCIENCE MONITOR
- Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
- (2015) Corinna Eichelser et al. Oncotarget
- microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
- (2015) Pierluigi Gasparini et al. Oncotarget
- Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer
- (2014) Todd A. MacKenzie et al. AMERICAN JOURNAL OF PATHOLOGY
- Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer
- (2014) Xiongwei Deng et al. BIOMATERIALS
- MicroRNAs as regulatory elements in triple negative breast cancer
- (2014) Melina-Theoni Gyparaki et al. CANCER LETTERS
- MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
- (2014) Brock Humphries et al. CARCINOGENESIS
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- miR-125bcan enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival
- (2014) Liang Zhang et al. GENES & DEVELOPMENT
- miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin
- (2014) Kristina Althoff et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1
- (2014) Xinsheng Shen et al. MEDICAL ONCOLOGY
- Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer
- (2014) Hong Yu et al. MEDICAL ONCOLOGY
- High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation
- (2014) Guizhi Dong et al. MEDICAL ONCOLOGY
- lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
- (2014) Gabriel Eades et al. MOLECULAR CANCER RESEARCH
- microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells
- (2014) YI REN et al. Molecular Medicine Reports
- miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer
- (2014) Jun Wang et al. Molecular Oncology
- miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
- (2014) Elisabetta Crippa et al. PLoS One
- A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
- (2014) Songjie Shen et al. PLoS One
- Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer
- (2014) Jinhua Hu et al. TUMOR BIOLOGY
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1
- (2013) X. Huang et al. CANCER RESEARCH
- Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer
- (2013) Andrea BISSO et al. CELL CYCLE
- MicroRNAs and Triple Negative Breast Cancer
- (2013) Elvira D'Ippolito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)
- (2013) Cindy Körner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
- (2013) Luciano Cascione et al. PLoS One
- MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
- (2013) Jie Gao et al. PLoS One
- Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1
- (2013) Hailing Liu et al. TUMOR BIOLOGY
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression Analysis of MiR-21, MiR-205, and MiR-342 in Breast Cancer in Iran
- (2012) Shahram Savad et al. Asian Pacific Journal of Cancer Prevention
- MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer
- (2012) Eylem Aydoğdu et al. CARCINOGENESIS
- Differential Expression of MicroRNAs in Different Disease States
- (2012) Maha Abdellatif CIRCULATION RESEARCH
- MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
- (2012) Marek Svoboda et al. Diagnostic Pathology
- High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients
- (2012) T. Toyama et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
- (2012) Haiyan Si et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- TGF-β upregulates miR-181a expression to promote breast cancer metastasis
- (2012) Molly A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
- (2012) Chen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
- (2012) Claudia Piovan et al. Molecular Oncology
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
- (2012) Sabrina M Lehmann et al. NATURE NEUROSCIENCE
- MicroRNA-302 Replacement Therapy Sensitizes Breast Cancer Cells to Ionizing Radiation
- (2012) Zhongxing Liang et al. PHARMACEUTICAL RESEARCH
- miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
- (2012) Erin N. Howe et al. PLoS One
- MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
- (2012) Wei Tang et al. PLoS One
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
- (2012) M. Fabbri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
- (2011) Mark Mackiewicz et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
- (2011) T. A. Farazi et al. CANCER RESEARCH
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- Down-regulation ofBRCA1expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers
- (2011) Amandine I. Garcia et al. EMBO Molecular Medicine
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade
- (2010) Khalid Sossey-Alaoui et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
- (2010) Patryk Moskwa et al. MOLECULAR CELL
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Suppression of cell growth and invasion by miR-205 in breast cancer
- (2009) Hailong Wu et al. CELL RESEARCH
- What is triple-negative breast cancer?
- (2008) William J. Irvin et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started